Recent evidence suggests that bacterial lipopolysaccharide binds to serum lipoproteins in vitro and in vivo and that lipopolysaccharide in the form that is bound to lipoprotein is less biologically active in several experimental models. In order to study the mechanism of this apparent detoxification, we compared the ability of free and lipoprotein-bound lipopolysaccharide from Escherichia coli 018 to stimulate interleukin-1, interleukin-6, and tumor necrosis factor from elicited murine peritoneal macrophages and circulating human monocytes. Lipopolysaccharide bound to lipoprotein was 20-to 1,000-fold less active than the unbound form in inducing the release of each cytokine. We also studied the binding of each form of lipopolysaccharide to the macrophage surface. Lipopolysaccharide complexed to lipoprotein was unable to compete for the binding of radiolabeled heterologous lipopolysaccharide to murine macrophages, and radiolabeled lipopolysaccharidelipoprotein complexes bound poorly compared with molar equivalents of free lipopolysaccharide. Our experiments suggest that in the process of binding to lipoproteins, lipopolysaccharide may be rendered less toxic through a mechanism of decreased ability to induce monocytes and macrophages to release cytokines, perhaps because of an altered interaction at the cel surface.
The role that bacterial endotoxin (lipopolysaccharide [LPS] ) plays in the pathogenesis of severe gram-negative infections has been studied for over 50 years. The majority of these investigations have utilized LPS that has been chemically extracted and then suspended in aqueous buffers. Over the last decade, however, it has been shown that LPS binds to lipoproteins (LP) in serum and plasma (15, 16, 28, 29) and that the resulting LPS-LP complex is much less active than unbound LPS in numerous assays of biological activity, including LPS-induced fever (16, 28) , neutropenia (28) , thromobocytopenia (29) , complement activation (28) , rate of development of hypotension (12) , and death in adrenalectomized mice (28) . Other studies have shown that the formation of LPS-LP complexes also occurs in vivo (16) and that LPS contained in membrane fragments binds to LP in a similar manner (16) .
There is considerable evidence that the binding of LPS to LP is altered in inflammatory serum. Tobias et al. (22) (23) (24) (25) have reported that the binding of LPS from rough mutant Salmonella minnesota Re 595 to LP is slower in inflammatory serum than in control serum. The delay is due to the formation of an intermediate complex of the LPS with a glycoprotein with a molecular weight of 60,000 called LPSbinding protein. Moreau and Skarnes, however, suggested in 1973 that LPS derived from smooth organisms incubated in tolerant rabbit serum underwent rapid transformation into a less toxic complex that contained LP (13) . We have confirmed that two other LPS derived from smooth organisms, Escherichia coli 0113 and Salmonella typhimurium, bind much more rapidly to LP in sera prepared from rabbits made tolerant to LPS (32) or in serum prepared from blood drawn after a single injection of interleukin-1 (IL-1) (33) than in normal serum. These experiments suggest that there are inducible humoral mechanisms that may function to de-* Corresponding author.
crease the bioactivity of smooth LPS by modulating LPS-LP binding (13, 18, 32, 33) .
Although two studies have indicated that the structure of LPS within the LPS-LP complex remains intact (15, 28) , there is little known about the mechanism(s) of the relative decrease in biological activity of the bound form. We previously reported that LPS-LP is less potent than unbound LPS in stimulating rabbit peritoneal macrophages to produce IL-1 (33) . These results raised several questions concerning the interaction of LPS with macrophages. First, it was unclear whether the decrease in IL-1 secretion represented a decrease in IL-1 production or normal IL-1 production with a decrease in IL-1 release, as has been recently described for LPS contained in liposomes (1). Second, it was unclear whether the secretion of both IL-la and IL-1lB is decreased and whether the release of other cytokines, such as tumor necrosis factor (TNF) and IL-6, is similarly decreased. Third, in our previous report we utilized only elicited peritoneal macrophages from rabbits, and it was not known whether macrophages from different species and different sources would behave in the same manner. Since injected LPS that is converted to the LPS-LP form is cleared from the bloodstream relatively slowly, with a half-life of 12 h (12), a relevant question was whether the LPS-LP could stimulate circulating monocytes. A final question was whether the LPS that is bound to LP is less able to bind to the macrophage surface.
In order to address these questions and in light of recent reports suggesting that cytokines such as IL-1, TNF, and IL-6 may play a direct role in the pathogenesis of endotoxic shock (2, 3, 26, 31) , we studied the interaction of the two forms of LPS with murine peritoneal macrophages and human circulating monocytes. We initially studied the release of IL-1, TNF, and IL-6 in response to LPS and purified LPS-LP. These findings confirmed that LPS-LP was less able to stimulate release of each cytokine and that the decrease in IL-1 resulted from a decrease in production rather than a block in secretion. We then employed a competitive-binding assay with radiolabeled LPS from Neisseria meningitidis to estimate the relative binding of each form of LPS to the macrophage surface (6) . We Rosklide, Denmark) in the absence of serum (11) . In these conditions, more than 85% of the adherent cells were monocytes, as assessed by morphological analysis by phase-contrast microscopy, histochemical staining for nonspecific esterase activity (27) IL-6 assay. IL-6 activity was determined by using the factor-dependent 7TD1 mouse-mouse hybridoma, which was the kind gift of J. Van Snick (Brussels, Belgium). IL-6 activity was assessed as described by Van Snick et al. (30) with minor modifications. Briefly, cells (2, well. Thereafter, the cells were harvested on glass-fiber filters with a cell harvester (Skatron). Thymidine incorporation was determined by liquid scintillation counting.
RESULTS
Induction of IL-1 by LPS and LPS-LP. IL-1 activity was found in the cell supernatants, on the cell membranes, and in the cell lysates of elicited murine peritoneal macrophages stimulated with both LPS and LPS-LP. However, LPS was 20-to 100-fold less active in the LPS-LP form than in the unbound form (Fig. 1) . Similar results were obtained with resident peritoneal macrophages (data not shown). When human circulating monocytes were studied, there was no IL-1 production or release induced by LPS-LP from human circulating monocytes even at the highest concentration studied (2 ,ug/ml), indicating a decrease in activity of at least 1,000-fold compared with that with unbound LPS (Fig. 2) .
Measurement of IL-la and IL-lp in these cell supernatants and lysates by radioimmunoassay was consistent with the results of the biological assays for each form of IL-1, although the magnitude of the difference was somewhat less (Table 1) . In both the human and mouse systems, the addition of free LP and LPS-LP to the LPS-macrophage incubations did not diminish the production or release of IL-1, confirming that serum components are necessary for the formation of LPS-LP (15) Induction of TNF by LPS and LPS-LP. The TNF activity in cell supernatants of elicited murine peritoneal macrophages stimulated with LPS-LP was markedly reduced in comparison with that with unbound LPS (Table 2 ; experiment performed twice). When human circulating monocytes were studied, free LPS induced TNF at concentrations of 2.0 to 200 ng of LPS/ml, whereas there was no TNF detected when the cells were stimulated with LPS-LP (Table 3 ; experiment repeated five times).
Induction of IL-6 by LPS and LPS-LP. LPS-LP induced markedly less IL-6 activity compared with LPS alone from murine peritoneal macrophages (Table 4) and circulating human monocytes (Table 5 ; experiment repeated three times).
LPS-macrophage binding. As described in Materials and Methods, we utilized a competitive-binding assay (10) macrophage membrane. A 10-fold excess of LPS (unlabeled N. meningitidis, E. coli 018, and E. coli 018 in the LPS-LP form) were incubated with the macrophages, followed by the addition of extrinsically radiolabeled LPS from N. meningitidis. The cells were then washed and evaluated for bound counts per minute. Homologous (N. meningitidis) and heterologous (E. coli 018) LPSs were able to compete for the binding of radiolabeled N. meningitidis LPS. In contrast, LPS-LP did not decrease this binding ( from N. meningitidis to murine peritoneal macrophages. These experiments confirmed that LPS in the LPS-LP form binds poorly to the macrophage membrane. Mitogenic assay. LPS-LP was slightly less mitogenic than unbound LPS for splenocytes from C3H/HePas mice ( Fig.  3A) and had essentially the same mitogenicity for splenocytes from BALB/c mice (Fig. 3B ). This experiment was repeated a total of three times with similar results. DISCUSSION Recent studies suggest that cytokines are important in the pathogenesis of endotoxic shock. Although the induction of IL-1, IL-6, and TNF by LPS is well known, the stimulation of these cytokines by LPS-LP has not been directly and systematically addressed. Investigation of the interaction of the LP-bound forms of LPS with macrophages seemed warranted because LPS-LP complexes may be the predominant form which circulates in the bloodstream (12) and because of recent studies which suggest that the binding of LPS to LP is modulated in inflammatory sera (22-25, 32, 33) . In addition, a study published after we had initiated our experiments suggested that the release of these cytokines by monocytes is inhibited by LP in human serum (8) .
We recently reported that LPS-LP is less able to induce IL-1 activity from peritoneal macrophages compared with free LPS (33) . Our present studies extend this finding in several ways. First, LPS-LP was much less active than unbound LPS in stimulating the release of IL-6 and TNF from macrophages. Such a finding was not unexpected for TNF because LPS-LP is apyrogenic even in microgram quantities (16, 28) , whereas TNF is a potent pyrogen (7). Second, our previous studies utilized only lapine peritoneal macrophages that were elicited with thioglycolate. Our present data indicate that LPS-LP is similarly less active in stimulating resident and elicited murine macrophages and circulating human monocytes. Third, our data indicate that both IL-la and IL-lp are diminished in monocyte supernatants stimulated with LPS-LP compared with unbound LPS and that the decrease in extracellular IL-1 from murine macrophages reflects a decrease in production rather than a block in its release. Fourth, we found that E. coli 018 LPS-LP was unable to compete for the binding of a heterologous extrinsically radiolabeled LPS to the macrophage surface, whereas molar equivalents of the unbound form of E. coli 018 LPS did compete for binding. Direct-binding experiments utilizing LPS and LPS-LP from N. meningitidis confirmed that LPS-LP bound poorly to the cell membrane. Finally, in an initial attempt to compare the activation of macrophages with the activation of splenocytes, we found that LPS-LP was only slightly less mitogenic than unbound LPS. These findings are consistent with the hypothesis that at least one mechanism by which LPS-LP is less toxic in vivo is that it is less able to induce the release of IL-1, IL-6, and TNF. Our findings are complementary to those of Flegel et al., who reported that LPS preincubated in 20% normal human serum was less active in stimulating human monocytes to produce IL-1, IL-6, and TNF compared with controls (8) . The decrease in cytokine release was not seen in delipidated serum but was found in delipidated serum reconstituted with LP prepared by ultracentrifugation. Although the degree of LPS-LP binding was not measured in this study, it seems likely that part or all of the inhibition may have been due to the formation of LPS-LP.
Of interest is a recent study in which macrophages incubated with LPS incorporated into liposomes were shown to release much less IL-1 than free LPS (1). Importantly, the intracellular and membrane-associated IL-1 were not decreased, suggesting that the production of IL-1 was normal but that the release of IL-1 did not occur (1). This was not the case with LPS-LP, in which both production and release were decreased. Our findings parallel our previous findings that gangliosides inhibit the production and release of IL-1 by macrophages (6) , presumably by forming LPS-ganglioside complexes (14) , which are then less able to stimulate the macrophage at the cell surface.
We hypothesize that LPS-LP is less able to stimulate the macrophage membranes because the LPS component of the complex is less able to interact with the macrophage surface. Such a notion is supported by our binding studies, although we cannot be certain that these two events are related. We have previously shown for different sorts of LPS-ganglioside complexes that the competition for LPS binding and IL-1 production and release are correlated (6) . Our studies are consistent with those of Freudenberg and Galanos (9), who reported that there was less LPS internalized into murine macrophages after 24 h of cultivation if the LPS was bound to high-density LP. (16) .
Our observation that LPS-LP was only slightly less mitogenic than LPS is curious when contrasted with the marked difference in the two preparations in stimulating macrophages. It is possible that this finding represents the longer incubation time of each preparation with the cells (48 versus 24 h). It may be, however, that the interaction of LPS with lymphocyte membranes involves mechanisms different from those of macrophages. A similar discrepancy between mitogenicity and IL-1-inducing activity has been observed with lipid A (4, 5) and with LPS complexed to gangliosides (unpublished observation). Further work will be needed to address this issue.
